Your browser doesn't support javascript.
loading
[SUSTAINABILITY OF RITUXIMAB IN CONCOMMITANT TREATMENT WITH METHOTREXATE OR LEFLUNOMIDE IN PATIENTS WITH RHEUMATOID ARTHRITIS].
Raitter, Ravit; Rimer, Doron; Boulman, Nina; Kaly, Lisa; Rozenbaum, Michael; Rosner, Itzhak; Odeh, Majed; Slobodin, Gleb.
Afiliación
  • Raitter R; Department of Internal Medicine A, Bnai Zion Medical Center, Haifa.
  • Rimer D; Rheumatology Unit, Bnai Zion Medical Center, Haifa.
  • Boulman N; Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa.
  • Kaly L; Rheumatology Unit, Bnai Zion Medical Center, Haifa.
  • Rozenbaum M; Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa.
  • Rosner I; Rheumatology Unit, Bnai Zion Medical Center, Haifa.
  • Odeh M; Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa.
  • Slobodin G; Rheumatology Unit, Bnai Zion Medical Center, Haifa.
Harefuah ; 156(7): 415-417, 2017 Jul.
Article en He | MEDLINE | ID: mdl-28786274
Asunto(s)
Buscar en Google
Imprimir
XML
PubMed Links

Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Metotrexato / Antirreumáticos / Rituximab / Isoxazoles Tipo de estudio: Observational_studies Límite: Humans Idioma: He Año: 2017 Tipo del documento: Article
Buscar en Google
Imprimir
XML
PubMed Links

Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Metotrexato / Antirreumáticos / Rituximab / Isoxazoles Tipo de estudio: Observational_studies Límite: Humans Idioma: He Año: 2017 Tipo del documento: Article